Nine Ten Capital Management is an investment fund managing more than $260 billion ran by Michelle Katauskas. There are currently 10 companies in Mrs. Katauskas’s portfolio. The largest investments include Cellebrite Di Ltd and Iradimed Corp, together worth $85.5 billion.
As of 7th August 2024, Nine Ten Capital Management’s top holding is 3,923,712 shares of Cellebrite Di Ltd currently worth over $46.9 billion and making up 18.0% of the portfolio value.
In addition, the fund holds 877,802 shares of Iradimed Corp worth $38.6 billion, whose value fell 3.9% in the past six months.
The third-largest holding is Stonex Group Inc worth $33.3 billion and the next is Agilysys, Inc worth $27.4 billion, with 263,460 shares owned.
Currently, Nine Ten Capital Management's portfolio is worth at least $260 billion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Nine Ten Capital Management office and employees reside in Chicago, Illinois. According to the last 13-F report filed with the SEC, Michelle Katauskas serves as the CCO/COO at Nine Ten Capital Management.
In the most recent 13F filing, Nine Ten Capital Management revealed that it had increased its stake in
Cellebrite Di Ltd and bought 452,514 additional shares worth around .
On the other hand, there are companies that Nine Ten Capital Management is getting rid of from its portfolio.
Nine Ten Capital Management closed its position in Olo Inc on 14th August 2024.
It sold the previously owned 1,861,663 shares for $10.2 billion.
Michelle Katauskas also disclosed a decreased stake in Stonex Group Inc by 0.4%.
This leaves the value of the investment at $33.3 billion and 442,491 shares.
The two most similar investment funds to Nine Ten Capital Management are Caden Capital Partners, L.P. and Bill Few Associates. They manage $260 billion and $260 billion respectively.
Nine Ten Capital Management’s portfolio is diversified across 5 sectors.
Currently, their heaviest sector is Consumer Discretionary — making up 20.7% of
the total portfolio value.
The fund focuses on investments in the United States as
70.0% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
approximately 0.1% of the total holdings value.
On the other hand, small-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $1.24 billion.
These positions were updated on August 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Cellebrite Di Ltd |
13.04%
3,923,712
|
$46,888,000,000 | 18.05% |
| Iradimed Corp |
8.46%
877,802
|
$38,571,000,000 | 14.85% |
| Stonex Group Inc |
40.57%
442,491
|
$33,324,000,000 | 12.83% |
| Agilysys, Inc |
47.04%
263,460
|
$27,437,000,000 | 10.56% |
| Sapiens Intl Corp N V |
344.68%
732,227
|
$24,844,000,000 | 9.56% |
| Winmark Corporation |
8.22%
68,500
|
$24,155,000,000 | 9.30% |
| Magnite Inc |
55.50%
1,652,793
|
$21,966,000,000 | 8.45% |
| Franklin Covey Co. |
13.43%
433,166
|
$16,460,000,000 | 6.34% |
| NV5 Global Inc |
18.05%
140,963
|
$13,105,000,000 | 5.04% |
| XPEL Inc |
20.04%
367,416
|
$13,065,000,000 | 5.03% |
| Olo Inc |
Closed
1,861,663
|
$10,221,000,000 | |
| SoundThinking Inc |
Closed
641,932
|
$10,194,000,000 | |
| Cogent Communications Hldgs |
Closed
93,612
|
$6,116,000,000 | |
| No transactions found | |||
| Showing first 500 out of 13 holdings | |||